In conclusion, this study shows that (i) Kv7.5 may be a useful therapeutic target in the treatment of canine osteosarcoma; and that (ii) the transcription factor Sp1 may play an important role in modulating Kv7.5 expression. This evidence concerns the gene KCNQ5 and osteosarcoma.